Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Cantor Fitzgerald
Queensland Health
Accenture
Federal Trade Commission
Chubb
Fuji
Moodys

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020928

« Back to Dashboard

NDA 020928 describes GLUCAGON, which is a drug marketed by Lilly and Fresenius Kabi Usa and is included in three NDAs. It is available from two suppliers. Additional details are available on the GLUCAGON profile page.

The generic ingredient in GLUCAGON is glucagon recombinant. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the glucagon recombinant profile page.
Summary for 020928
Tradename:GLUCAGON
Applicant:Lilly
Ingredient:glucagon recombinant
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020928
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLUCAGON glucagon recombinant INJECTABLE;INJECTION 020928 NDA Eli Lilly and Company 0002-8031 N 0002-8031-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/VIAL
Approval Date:Sep 11, 1998TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Cantor Fitzgerald
Moodys
UBS
Julphar
Medtronic
Argus Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.